𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erythropoietin in aplastic anemia

✍ Scribed by Pavlovic-Kentera, V. ;Milenkovic, P. ;Ruvidic, R. ;Jovanovic, V. ;Biljanovic-Paunovic, L.


Publisher
Springer-Verlag
Year
1979
Weight
366 KB
Volume
39
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effect of androgen therapy and anemia on
✍ Piedras, Josefa; HernΓ‘ndez, Guadalupe; LΓ³pez-Karpovitch, Xavier πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 53 KB πŸ‘ 2 views

Immunoreactive serum erythropoietin (EPO) was measured in anemic and non-anemic patients with acquired non-severe aplastic anemia (AA; n = 22) and myelodysplastic syndromes (MDS; n = 31) receiving or not androgens to examine the effect of androgen therapy and anemia on EPO levels in these disorders.

Combination Therapy With Recombinant Hum
✍ Dr. Masahiro Imamura; Masanobu Kobayashi; Sumiko Kobayashi; Kohki Yoshida; Chika πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 430 KB πŸ‘ 1 views

## Abstract Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) and erythropoietin (rhEPO) were used to treat patients with aplastic anemia (AA). In terms of effects on erythrocyte recovery, the combined use of rhG‐CSF and rhEPO showed a favorable response in 6 of 14 (42.9%) patients

MRI findings in aplastic anemia
✍ Rebecca Loret De Mola; Peter Kurre πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 2 views
Aplastic anemia in the orient
✍ Seiji Kojima πŸ“‚ Article πŸ“… 2002 πŸ› Carden Jennings Publishing 🌐 English βš– 469 KB